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Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common cause of demen-
tia in the elderly. The extracellular accumulation of amyloid-β (Aβ) in senile plaques is a principal
event in the pathogenesis and there is growing evidence that the dysregulation of lipid pathways
is implicated in the disease, however the link between these two is still under study. In this work,
we investigated human brain samples, from 11 AD patients and a control cohort of age-matched
subjects without AD, using label-free chemically-specific Raman micro-spectroscopy. The collected
image data were quantitatively analysed using an efficient quantitative unsupervised/partially su-
pervised non-negative matrix factorization method, to retrieve the concentration maps and spectra
of the samples’ chemical constituents. Significant changes in lipid composition as well as increased
concentrations of oxidative stress bio-markers were observed in AD tissues compared to the control.
In particular, the analysis revealed accumulations of two different lipid components throughout the
entire Aβ plaque (highest at the fibrillar core and lowest at the rim). One component is attributed to
cholesteryl esters with saturated long-chain fatty acids (FAs), found to co-localise with aggregated
Aβ peptides in multi-clusters of about 3µm average size, which are in turn bundled to each other
forming one macro-aggregate templating the Aβ plaque. The other component is attributed to a
mixture of fibrin protein and arachidic acid, which are a hallmark of inflammation, and was found
to be abundant in fibrillar and core-only plaques. This fibrin/arachidic acid component showed
multiple domains of different sizes, ranging from 1 to 5µm, linked to each other and forming a large
structure of shape similar to the plaque. Lipid aggregates and Aβ plaque cores for the AD group were
also found to be co-localised with significant accumulations of β-carotene and magnetite (Fe3O4),
indicating a high level of oxidative damage implicated in AD human brains. In addition, a non-
Aβ protein component was observed to co-deposit with the fibrillar core of hippocampal Aβ plaques,
and was attributed to a collagen-like amyloidogenic component (CLAC). Overall, our results reveal
abnormal deposits of saturated cholesteryl esters, Aβ fibrils, arachidic acid, fibrin, CLAC, β-carotene
and magnetite, co-localising in Aβ plaques of AD human brains. This finding opens perspectives
for new anti-inflammatory and antioxidant drug strategies, designed to restore brain homeostasis
as potential therapeutics of AD. We also demonstrate by the means of spatial concentration his-
tograms that these identified species separate AD from non-demented control brains, beneficial for
AD diagnosis.
I. INTRODUCTION
Alzheimer’s disease (AD) is an age-related neurodegen-
erative disorder, characterized by the extracellular accu-
mulation of Aβ peptide in senile plaques and the intracel-
lular deposits of the microtubule-associated protein tau
in the form of neurofibrillary tangles. According to the
2017 Alzheimer’s Association report, AD affects one in
nine Americans over the age of 65 and becomes increas-
ingly prevalent with age [1]. Alongside obesity and dia-
betes, AD is a modern disease with consistently increas-
ing number of patients. Despite being considered as a
21st century epidemic, there is still no cure for AD and
the etiology of the disease remains obscure. A number of
hypotheses such as amyloid cascade, lipid dysregulation,
oxidative stress, and inflammation have been proposed
∗Electronic address: Moreva@physics.msu.ru
†Electronic address: BorriP@cardiff.ac.uk
for the AD pathogenesis, suggesting that AD is a multi-
factorial complex disorder.
Aβ plaques, lipids and neuroinflammation can be con-
sidered as the three main hallmarks of AD. Indeed, it
has been shown that the aggregation of Aβ is mediated
by the interaction with different classes of lipids, includ-
ing cholesterol [2–4], ganglioside [5–7], phospholipids [8, 9]
and fatty acids (FAs) [10], which activates the innate im-
mune system and then induces a cascade of pathological
events such as neuroinflammation and oxidative stress.
Interestingly, in highly oxidative environment, charac-
terized by high level of reactive oxygen species (ROS)
as well as redox metal ions, lipids become oxidized [11].
The products of lipid peroxidation are very reactive with
other biomolecules and, consequently, neurotoxic [12, 13].
As an evidence, it has been shown that 4-hydroxy-2-
trans-nonena (HNE), the product of lipid peroxidation,
can covalently modify the histidine side chains of Aβ,
leading to increased aggregation of this peptide [14]. In
addition, neprilysin (NEP), a major protease that cleaves
Aβ in vivo, has also been reported to be HNE modified
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2in AD brain [15]. On the other hand, there is a line of
evidence that lipids themselves have detergent proper-
ties, promoting the disintegration of amyloid fibrils into
toxic oligomers [16, 17]. These free oligomers can bind
to synaptic contacts [18], where they disrupt membrane
homeostasis [19]. Altogether, these findings suggest that
the amyloid-lipid complex in Aβ plaques produces toxic
species, which are involved in AD’s pathology.
Despite the importance of this research, the direct
molecular analysis of Aβ plaques and their lipid inclu-
sions in human AD brains, with quantitative information
on their spatial distribution and chemical composition,
is still very limited. This is partly due to the lack of
reliable methods to study lipids with high spatial reso-
lution and chemical specificity in their native microenvi-
ronments. Of the imaging tools available, fluorescent mi-
croscopy (FM) revealed abnormal deposits of cholesterol
in cores of mature Aβ plaques [20]. However, this tech-
nique is based on tagging the biomolecules of interest, not
allowing to study unknown chemical species. Further-
more, labelling can affect the distribution/composition
of the fragile lipids/amyloid co-arrangements. Among
spectroscopy techniques, mass spectrometry (MS) pro-
vides chemical information on a wide range of molec-
ular contents with high specificity, but requires sample
ionization as well as chemical extraction of lipids from
tissue samples. For example, liquid chromatography-
MS (LC-MS) showed an elevated level of diacylglyc-
erol (∼80% ↑), glucosylceramide (∼43% ↑) and galac-
tosylceramide (∼32% ↑), as well as decreased phos-
phatidylethanolamine (∼25% ↓) in the prefrontal cor-
tex human brain with AD compared to controls. Fur-
thermore, the AD entorhinal cortex subjects were found
to be enriched in lysobisphosphatidic acid (∼80% ↑),
sphingomyelin (∼20% ↑), ganglioside GM3 (ceramide-N-
tetrose-N-acetylneuraminic acid) (∼64% ↑), and choles-
terol esters (CE) (∼70% ↑) in the form of CE-16:1, CE-
16:0, and CE-18:1, which are typically associated with
lipid droplets [21]. It is possible to combine MS with
imaging and achieve spatial resolution from tens of mi-
cron (with MALDI) to sub-micron (with second ioniza-
tion mass spectrometry-SIMS). These MS-based imaging
modalities have been applied to image lipid, proteins and
metals in brains [22, 23], however they require sample
processing procedures which are damaging and destruc-
tive and can not be applied to living specimens.
Vibrational micro-spectroscopies techniques such as
infrared absorption [24, 25] and Raman scattering mi-
croscopy detect the intrinsic vibrations of chemical bonds
in molecules, and thereby provide a non-invasive, label-
free chemically specific imaging method. Infrared mi-
croscopy has limited spatial resolution due to the long
wavelength of the infrared light. Conversely, Raman
micro-spectroscopy can offer sub-micron spatial resolu-
tion by using light in the visible range. Notably, in its
non-linear version, coherent Raman scattering (CRS) mi-
croscopy provides additional improvements in 3D spa-
tial resolution and acquisition speed compared to spon-
taneous Raman, and has been recently applied to study
brain tissues [26–28]. However CRS suffers from limited
signal-to-noise ratio in the vibrational fingerprint range
(700-1800 cm−1), and in turn reported studies of CRS mi-
croscopy of brain tissues examined only the CH-stretch
vibrational range (2700-3100 cm−1), which is notoriously
more congested than the fingerprint region and thus less
chemically specific. Surprisingly little work has been re-
ported to date on the chemical profile of AD brains by
confocal Raman micro-spectroscopy [29, 30], and a com-
prehensive quantitative analysis of the spatially-resolved
chemical composition of the lipid-amyloid complex, cov-
ering the whole spectral range from fingerprint to CH-
stretch, in unstained AD human brain tissues is still miss-
ing.
In this work, we report an extensive study of
the spatial distribution and chemical composition of
Aβ plaques, measured by label-free spontaneous Raman
micro-spectroscopy in fixed human brain slices from AD
patients and age-matched controls and quantified by hy-
perspectral image factorization method.
II. EXPERIMENTAL SECTION
A. Tissue preparation
Human brain tissue was obtained from the Thomas
Willis Oxford Brain Collection (TWOBC), which is part
of the Medical Research Council (MRC) Brain Bank Net-
work, with the ethical approval of the Research Tissue
Bank provided by the Oxford Brain Bank (OBB) Access
Committee. Brain tissue samples were recruited from 11
individuals, who at the time of death had AD, and from
4 age-matched humans, which were not diagnosed with
AD based on histological examination (see Table 1). The
AD brain cohort met the standard criteria for AD’s neu-
ropathologic diagnosis. A total of 5 hippocampal and 6
cerebral cortex diseased samples were investigated, rep-
resenting the hippocampus of the first five AD subjects
and the frontal lobe of the other six ones. As control, 2
hippocampal and 2 cerebral cortex samples from the cor-
responding brain regions of non-demented subjects were
included in this study. Brain samples were fixed with
formalin, paraffin embedded, sectioned into 5 µm thick
slices and then mounted on standard glass slides. For Ra-
man micro-spectroscopy measurements, formalin-fixed-
paraffin-embedded brain sections were deparaffinized us-
ing a standard dewaxing protocol: removing the paraffin
in xylene (two cycles for 20 minutes each), and rehy-
drating in a sequence of 100%, 90% and 70% ethanol for
5 minutes each. The slices were then covered with phos-
phate buffered saline (PBS) and a standard glass cover-
slip was attached on top. Finally, the mounted samples
were sealed with nail varnish applied around the edges of
the coverslip. After Raman measurements, the samples
were reopened and stained with Thioflavin-S for amy-
loid fibrils to confirm plaque locations. In the following,
3TABLE I: Clinical characteristics of study participants
Case Number Age in years Gender Neuropathological diagnosis The degree of AD pathology [31] Brain region
Ah1 92 F AD Severe Hippocampus
Ah2 87 F AD Severe Hippocampus
Ah3 73 M AD Modereate Hippocampus
Ah4 70 M AD Mild/Moderate Hippocampus
Ah5 85 F AD Moderate Hippocampus
Ac1 75 M AD Moderate Frontal Lobe
Ac2 82 F AD Severe Frontal Lobe
Ac3 85 F AD Severe Frontal Lobe
Ac4 80 M AD Moderate Frontal Lobe
Ac5 76 M AD Moderate Frontal Lobe
Ac6 77 M AD Moderate Frontal Lobe
Ch1 59 M Control Normal Hippocampus
Ch2 61 F Control Normal Hippocampus
Cc1 64 M Control Normal Frontal Lobe
Cc2 60 F Control Normal Frontal Lobe
we refer to AD and control (C) samples, numbered by
individual, as Ah1,..., Ah5 and Ch1, Ch2, respectively,
studied in the hippocampus; and as Ac1,..., Ac6, and
Cc1, Cc2, studied in the cerebral cortex. A total of
61 Aβ plaques were examined: 30 in the five hippocampal
brain samples and 31 in the six cerebral cortex samples
from the 11 AD subjects. Specifically, there were: 10,
9, 5, 1, and 5 plaques in the Ah1, Ah2, Ah3, Ah4, and
Ah5 hippocampal samples, respectively; and 3, 13, 7, 2,
3, and 3 plaques in the Ac1, Ac2, Ac3, Ac4, Ac5, and
Ac6 cortical samples.
B. Optical micro-spectroscopy
Raman imaging was carried out using a home-built
multimodal laser-scanning microscope based on an in-
verted Nikon Ti-U stand, coupled to a Horiba Jobin-
Yvon iHR 550 imaging spectrometer (300 grooves/mm
grating) and an Andor CCD Newton DU-971N-BV de-
tector (1600x400 pixels, 16µm pixel size). A laser source
(Laser Quantum GEM 532 nm) was used for excitation.
The 532 nm laser excitation was filtered by a Semrock
LL01-532 clean-up filter, and coupled into the microscope
by a dichroic mirror (Semrock LPD01-532RS). Raman
scattering was collected in epi-direction, filtered with a
long pass filter (Semrock BLP01-532R), and dispersed by
the imaging spectrometer. The spectral resolution of the
system was 5 cm−1 with 30 µm width of the spectrome-
ter entrance slit, and the measured Raman spectral range
covered 330 cm−1 to 4050 cm−1.
Raman imaging for all brain samples was achieved
by raster-scanning the sample, using a motorized stage
(Prior ProScan III XYZ Controller), through the fo-
cal point of the laser beam over a region of interest of
about 50 × 50µm2 with a step size of 1µm resulting in
a 50×50×1600 points hyperspectral Raman image with
a 1 second exposure time per spectrum. All images were
taken with 100 mW laser power at the sample, using
a 20× 0.75 NA dry objective (Nikon MRD00205) and
1× tube lens. Confocal Raman detection was provided
by a horizontal slit (Thorlabs VA100), and the vertical
input slit of the spectrometer, both located in an inter-
mediate image plane. The estimated spatial resolution
was 0.45µm in-plane and 0.6µm axially.
Prior to Raman measurements, an overview image for
each sample across 10.4 × 6 mm2, made of 24 × 18 tiles
with 0.43 × 0.33 mm2 tile size, was acquired using dif-
ferential interference contrast (DIC). In the DIC, a de-
Senarmont compensator provided a phase offset of 20 de-
grees and a 0.72 NA dry condenser (Nikon MEL56100)
with a DIC module (Nikon MEH52400) was used for il-
lumination, combined with a matched DIC slider (Nikon
MBH76220) in the objective, giving a shear of about
0.24µm. A Hamamatsu ORCA 285 camera (1344×1024
pixels of 6.45µm size) at 100 ms frame exposure time
was used for detection at lowest gain (4.45 photoelec-
trons/count).
For imaging of the Thioflavin-S stained samples, wide-
field epi-fluorescence microscopy was implemented in the
same microscope set-up using a Prior Lumen 200 (stan-
dard) 200W fluorescence illuminator light source, and a
filter set consisting of a single band exciter (Semrock
FF01-370/36) transmitting 352-388 nm, a single band
dichroic (Semrock FF409-Di03) at 409 nm, and a single
band emitter (Semrock FF02-447/60) transmitting 417-
477 nm. Each image was acquired with 200 ms exposure
time and 10% lamp power.
4C. Data analysis and processing
Raman hyperspectral data were analysed using
quantitative unsupervised/partially supervised unmix-
ing method [32], consisting of the following basic steps
(see also the theory, algorithms and data analysis steps
in [32]). Firstly, the data were noise-filtered using
singular-value decomposition (SVD) with automatic di-
visive correlation, enabling to remove components which
are identified as noise using the auto-correlation coef-
ficients for spatial and spectral singular vectors at one
pixel shift. Components with a mean auto-correlation
coefficient less than 50% were attributed to noise and
discarded. This cut-off value was suited to differentiate
the meaningful components from noise-dominated ones,
as verified by visual inspection and discussed in [32].
Secondly, broad features in the spectra, which represent
fluorescent background, were subtracted using the bot-
tom Gaussian fitting with a standard deviation (STD)
of 900 cm−1. Finally, the efficient quantitative unsu-
pervised/partially supervised non-negative matrix fac-
torization (Q-US/PS-NMF) method via a fast com-
binatorial alternating non-negativity-constrained least
squares (ANLS) algorithm was applied to the noise-
filtered background-subtracted data. This algorithm [32]
factorizes the spectrally and spatially resolved data into
a sum of direct products of non-negative spatial con-
centration maps and corresponding non-negative spec-
tra, representing biochemical components of sample com-
position, showing an exponential convergence towards a
global minimum. In the factorizations shown here, the
remaining factorization error was about 2%. In order to
compare the concentrations of different chemical species
between samples, the component spectra were normal-
ized to have equal integrals, having a value chosen to
result in a sum of the spatial concentrations with a mean
of one.
In order to separate the contribution of wax residues
to the spectral basis, the spectrum of the paraffin-wax
compound, measured on one of the paraffin-embedded
sample, was used as a fixed spectral component in the Q-
US/PS-NMF. The Raman spectrum of wax is also shown
in Figs. S11 and S33 of the Supporting Information, to-
gether with the results of factorization analysis of hip-
pocampal and cortical brain tissues.
III. RESULTS AND DISCUSSION
Label-free confocal Raman micro-spectroscopy to-
gether with hyperspectral image factorization method
(see Sec. II B and Sec. II C) was used to investigate the
biochemical composition of Aβ plaques and their envi-
ronment in AD human brain tissues from the hippocam-
pus and frontal lobe. The quantitative data analysis was
performed simultaneously on all data of a given type of
brain region (i.e. hippocampus or cortex), enabling a di-
rect comparison of concentration and spatial distribution
of chemical components in diseased and control samples.
To identify Aβ plaques, the samples were stained with
Thioflavin-S (the ”gold standard” for identifying amy-
loid fibrils [33]). This was done after Raman imaging,
to avoid labelling artefacts and fluorescence background.
To identify potential areas containing plaques on label-
free AD samples, we used large scale DIC images. DIC
contrast allowed us to identify Aβ plaques regions, which
were used for the area selection for Raman measurements
of label-free AD samples. To confirm they are plaque-
positive, we performed FM of the measured regions on
the same samples stained with Thioflavin-S dye.
The factorization analysis revealed that all hyperspec-
tral images were optimally represented using 20 sepa-
rate components. Detailed discussion on the components’
number selection can be found in [32]. In brief, when us-
ing 19 components, the algorithm resulted in a higher
concentration error, whereas for 21 components one fac-
torization component with a meaningful spectrum which
could be attributed to proteins split into two less mean-
ingful ones. Five of these components were found to be
spatially co-localized with the Aβ plaques, and exhib-
ited spectra resembling those of known chemical species,
as detailed in the following section. We call these com-
ponents C1..C5 in the following, sorted in the order of
decreasing mean concentration. Notably, four of them
were similar in the hippocampal and cortical brain sam-
ples, with the remaining one was seen only in the hip-
pocampus. The other 15 components were not signif-
icantly colocalized with Aβ plaques. Their description
and attribution is given in the Supporting Information.
A. Raman spectra of chemical components
colocalized with hippocampal Aβ plaques
The spectra of the 5 chemical components C1...C5 co-
localized with Aβ plaques in hippocampal samples in
the fingerprint (736-1780 cm−1) and CH-stretch (2793-
3122 cm−1) regions are given in Fig. 1. They were
obtained analysing data from 30 regions containing
Aβ plaques from AD subjects and 10 regions from
the control group (see Sec. II A). The ranges below
736 cm−1and above 3200 cm−1are dominated by Raman
scattering from the glass slide/coverslip and water, re-
spectively, and were therefore excluded from the analy-
sis.
Raman spectra of analytical standards, which resem-
ble the component spectra, are shown for comparison.
They were identified using Bio-Rad’s KnowItAll Vibra-
tional Spectroscopy software with the Raman Spectral
Libraries. The Raman spectra of the identified standards
shown in this work were then taken from published pa-
pers and are cited accordingly in the following.
The spectrum of C1 exhibits a series of char-
acteristic bands, at 1657 cm−1 (Amide I, α-helix),
1554 cm−1 (Amide II), 1338 cm−1 (CH2 wagging vibra-
tions from glycine (Gly) backbone and proline (Pro)
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FIG. 1: Raman spectra (blue solid lines) of the five
chemical components C1...C5 co-localized with hippocampal
Aβ plaques, as indicated. For each component, spectra of
mixtures of analytical standards are shown (red dotted lines),
with spectra of the constituents shown as green and magenta
lines, offset and scaled for clarity.
side chain), 1267 cm−1 (Amide III), 1206 cm−1 (hydrox-
yproline (Hyp) and tyrosine (Tyr)), 1031 cm−1 (Pro),
1002 cm−1 (phenylalanine), 934 cm−1 (C-C backbone),
852 cm−1 (Pro, Hyp, Tyr), which are consistent with
the Raman bands of collagen [34]. Furthermore, the
spectrum shows a notable band at 1705 cm−1, which is
characteristic for the C=O stretching vibration of amino
acids. This band might be originated from Gly-Pro-X
and Gly-X-Hyp sequence (where X is any amino acid),
which are the most common motifs of collagen.
It has been previously reported that senile plaques ex-
tracted from AD human brains contain a collagen-like
amyloidogenic component (CLAC), which is associated
with collagen XXV [35]. In vitro studies show that addi-
tion of a collagen-like triple-helical peptide to the amy-
loidogenic peptide significantly delays its nucleation and
fibril growth [36]. Relating to the C=O vibration ob-
served for C1, these studies hypothesised that the C=O
moieties in the repeating Gly-Pro-Hyp sequences within
the triple-helix collagen can bind to backbone amides or
to glutamine/asparagine side chains of the amyloid-like
peptide, hampering its nucleation. Other relationships
between collagen and amyloid suggest the neuroprotec-
tive potential of collagen VI against Aβ neurotoxicity by
blocking the association of Aβ oligomers with neurons,
protecting against fragmentation of Aβ plaques, thereby
preventing neurotoxicity [37].
The spectra of C2 and C3 show bands characteristic of
a mixture of lipids, with C2 additionally showing bands
that can be related to proteins. In particular, the fin-
gerprint region of C3 exhibits bands at 1060, 1129, and
1293 cm−1, assigned to C-C skeletal stretching vibra-
tions, and the CH2 twisting mode of fatty acids, respec-
tively [38, 39]. The presence of a strong 2880 cm−1 band
in the CH-stretch region (the asymmetric CH2 stretch
enhanced by the Fermi resonance interaction with the
overtones of CH2 and CH3 deformations) combined with
a relatively weak band around 2933 cm−1 (a combina-
tion of CH3 and CH2 asymmetric vibrations enhanced
by the broadening and shift of the CH deformations in
the liquid phase) [40], is typical of a saturated lipid in
the solid phase. We find that the spectrum of C3 can be
well described (using reference spectra and NLS fitting)
as a mixture (red dotted line) of 79% fibrin (magenta
line) [41] and 21% arachidic acid (green line) [39] in both
the fingerprint and CH-stretch regions. We therefore at-
tribute C3 to a mixture of fibrin protein and saturated
FA, resembling arachidic acid. This observation is in line
with previous studies on fibrin deposition in plaque areas
of AD mouse brains [42]. Furthermore, the same studies
have suggested that fibrin might play a central role in the
initiation and progression of the inflammatory process
in AD, possibly promoting neurodegeneration. Neuronal
damage of AD brains correlated with fibrin deposits is
supported by our observation, revealing co-deposition of
arachidic acid, as a marker of oxidative damage in tissue,
with fibrin.
The spectrum of C2 reveals an acyl chain order, given
by the ratio between the intensity at 2880 cm−1 and at
2850 cm−1, twice as high as C3, and a strong band at
1673 cm−1, which can be attributed to the superposition
of the C=O stretching vibration of the protein backbone
(Amide I band) from a high content of β-sheet protein
structure, with the C=C stretching vibration mode in
cholesterol [38] and in the FA chain of E -unsaturated
6FAs (trans-configuration) [34]. Notably, the formation
of trans double bonds (1670 cm−1) results from the con-
version of cis double bonds (1655 cm−1 - not present in
C2) during lipid peroxidation [43]. The spectrum of C2 in
the fingerprint region can be well described (red dotted
line) by a mixture of 81% of synthetic Aβ (1-42) fibrils
(spectrum available only in the fingerprint region [44]),
which can be associated with the core of Aβ plaques with
predominately β-sheet protein structure (magenta line),
and 19% cholesteryl palmitate (green line) [39]. The CH-
stretch region is found to be similar to the reference spec-
trum of cholesteryl palmitate. We therefore attribute
C2 to a mixture of two chemical constituents: Aβ (1-
42) peptide, aggregated in amyloid fibrils with β-sheet
confirmation, and cholesteryl derivatives with saturated
long-chain FA chains, forming lipid aggregates. The oc-
currence of this mixed component in the analysis indi-
cates that the constituents are co-localized within the
spatial resolution of the data, suggesting that amyloid
and cholysteryl-ester lipid bodies form a tightly con-
nected structure in the samples. The combination of
Aβ protein and cholesteryl ester was discussed in previ-
ous studies on cholesterol-mutant cell lines, where it was
found that Aβ generation is up-regulated with a selec-
tive increase of cholesteryl ester levels, regulated by acyl-
coenzyme A:cholesterol acyltransferase (ACAT)[45]. The
same studies have shown that pharmacological ACAT in-
hibitors sufficiently suppress both cholesteryl ester and
Aβ biosynthesis, indicating their potential for use in the
therapy of Alzheimer’s disease. Recently, this strategy
has been confirmed on an AD mice model [46]. Fur-
thermore, the solid lipids might be associated with lipid
droplets, originated either from microglia or the lipid
transporter protein apolipoprotein E (ApoE). The for-
mer is suggested by previous observations that lipid
microvesicles, secreted by microglia, are shown to ad-
here to fibrillar plaques, from where they extract toxic
Aβ oligomers, implying one of the possible mechanism of
lipid deposition [47]. The latter is suggested by a study
showing that the ApoE-lipid complex binds to fibrillar
Aβ plaques, where it modulates its aggregation and clear-
ance [48].
The spectrum of C4 shows three sharp bands char-
acteristic of carotenoids, at 1007 cm−1, 1154 cm−1, and
1518 cm−1, which can be assigned to the methyl rock-
ing vibrational mode, C-C, and C=C in-phase stretch
vibrations of the polyene chain, respectively [49]. Fur-
thermore, the relative intensities of the bands are com-
parable with those for pure β-carotene (red dotted line),
confirming its attribution to β-carotene. Notably, this
component is particularly enriched in cortical plaques,
as will be detailed in Sec. III D. Note that while average
carotenoid concentrations in control and AD brain tissue
from the frontal lobe and occipital cortex have been re-
ported, which for β-carotene species account for 4.5 ng/g
in Alzheimer’s brains compared to 5.5 ng/g in normal
elderly ones, there is still no information about its spa-
tial distribution and correlation with Aβ plaques. Fur-
thermore, the role of β-carotene and other carotenoids in
lipid peroxidation in free radical-affected diseases, such
as AD, cardiovascular diseases, atherosclerosis, and can-
cer is controversial [50, 51]. For example, it was shown
in vitro that β-carotene can act as either anti- or pro-
oxidant depending on its concentration and the oxygen
partial pressure in tissue [52].
The spectrum of C5 is found to be consistent with
Fe3O4 [53] (see red dotted line). In fact, the presence of
redox metal ions including iron has been observed for AD
brains, making them vulnerable to oxidative damage [54].
Furthermore, it has been recently observed by electron
holography that iron nanoparticles co-localise with the
cores of Aβ plaques [55]. There is growing evidence that
a high affinity of Aβ peptides for metal ions results in
the formation Aβ-metal complexes, and that metal ions
in turn induce the oligomerization of toxic Aβ species [56].
B. Concentration maps of chemical components in
hippocampal Aβ plaques
In this section, we examine and compare the spatially-
resolved maps of the concentrations of the chemical
components identified in the previous section, across
AD and non-demented populations in the hippocam-
pal brain region. Fig. 2 shows representative examples
of Aβ plaques with different morphologies, namely fib-
rillar (Fig. 2A, 70 × 70µm2 from Ah1), cored neuritic
(Fig. 2B, 60 × 60µm2 from Ah2 ), core-only (Fig. 2C,
40 × 40µm2 from Ah3) and diffuse neuritic (Fig. 2D,
50×50µm2 from Ah4), and two control regions (Fig. 2E,
64 × 64µm2 from Ch1, and Fig. 2F, 50 × 50µm2 from
Ch2). Row 1 shows DIC images taken before Raman
imaging, and Row 2 shows fluorescent images of the same
plaques, taken after staining with Thioflavin-S, with the
white squares indicating the regions of Raman imaging.
Rows 3 to 7 show the concentrations of C1 to C5, respec-
tively. The concentration maps exhibit an accumulation
of the selected components in plaque areas compared to
control regions. Generally, C1 (CLAC), C2 (fibrillar Aβ (1-
42) and saturated cholesteryl esters), and C3 (fibrin and
arachidic acid) show a similar spatial distribution.
In the fibrillar plaque, C1, C2, and C3 are clustered
in multi-domains of various sizes, which are linked to
each other, forming one macro-aggregate, templating the
plaque. Notably, the distribution of C5 (iron oxide) is
co-localized with C1, C2, and C3, except from small high
density clusters, which seem to exclude the other compo-
nents. C4 instead is essentially absent.
The cored neuritic plaque, apart from being more spa-
tially localized, shows a similar contribution of the dif-
ferent components, except for the collagen component,
which is not observed in its oligomeric halo, as seen from
the void areas in its concentration map (Fig. 2B3), which
are filled by iron (C5) in the centre, and lipids (C3) around.
The core-only plaque shows higher concentrations and
a high degree of co-localization of all components. Fur-
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FIG. 2: Images of Aβ plaques with different morphologies and of control regions. Columns A-D show fibrillar, cored neuritic,
core-only, and diffuse neuritic plaques, from Ah1, Ah2, Ah3 and Ah4 samples, respectively, and columns E-F show control
regions from Ch1 and Ch2 samples. Row 1: DIC images taken before Raman imaging. White squares indicate the regions
of Raman measurements. Row 2: Epi-fluorescence images of the same regions as measured in DIC, taken after staining with
Thioflavin-S. Rows 3-7: spatial distributions of the concentration of C1..C5, on color scales as indicated. The concentrations in
panel D3, D4 is scaled by a factor of two for visibility. The corresponding component spectra are given as white lines in the
first column (see also Fig. 1). Scale bars: 10µm.
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FIG. 3: Colocalization histograms of concentration (%) for C2 - C3 (upper row) and for C2 - C1 (lower row) for each diseased
(4 AD patients) and control (2 subjects) hippocampal samples, which refer to AD and non-demented age-matched subjects,
labelled according to the sample source as Ah1, Ah2, Ah3, Ah5, Ch1, and Ch2, and representing the statistics on 10, 9, 5, 5
plaques, and 6, 4 control regions, respectively, each of about 50×50 µm2 in size.
thermore, a significant concentration of C4 (β-carotene)
is found surrounding the core of plaque.
The diffuse neuritic plaque has a similar morphology
as the fibrillar plaque, but with lower concentrations of
each component, except C4. Notably, C2 and C5 are found
not to be co-localized.
In contrast to plaque areas, the two control regions
have smaller concentrations of C2, C3, C4, and C5. How-
ever, C1 is found to have relatively high concentrations,
which are rather evenly distributed, representing extra-
cellular matrix.
Fig. 3 shows the colocalization histograms of the con-
centrations of C2 and C3 (top row) and of C2 and C1 (bot-
tom row) for AD and control, combining data from 10, 9,
5, 5 plaques from Ah1, Ah2, Ah3, Ah5, and 6, 4 control
regions from Ch1, Ch2 individuals, respectively, each of
about 50×50 µm2 in size. The colocalization histograms
for Ah4 sample is shown in the Supporting Information
Fig. S22. The analysis of these histograms reveals a sig-
nificant difference in concentrations of collagen, Aβ (1-42)
fibrils, saturated cholesteryl esters, fibrin and arachidic
acid between AD and control groups, indicating their po-
tential to be used for discrimination of patients’ classes.
In particular, as can be seen from Fig. 3, we can take a
cut-off value of the distributions histograms at concen-
trations of 15%, 5%, and 15%, 28% for components 2,
3 (top row) and components 2, 1 (bottom row), respec-
tively, which results in only histograms for AD group
having concentrations higher than these values, therefore
indicating that the hippocampal AD samples are differ-
entiated from the non-AD controls on the basis of these
concentration distributions.
C. Raman spectra of the chemical components in
cortical Aβ plaques
From our Raman micro-spectroscopy measurements
and quantitative factorization analysis on cortical AD
samples together with non-demented controls, we find
four key chemical components, which are co-localized
with cortical Aβ plaques. These are: a mixture of fibrillar
Aβ (1-42) and saturated lipids with cholesteryl deriva-
tives (C2), a mixture of cholesterol and cholesteryl es-
ters with saturated FA chains (C3), β-carotene (C4) and
Fe3O4 (C5) (see the Supporting Information Figure S46).
Notably, there is no signature of collagen (C1 in the hip-
pocampus) observed in the cortical plaque regions.
D. Concentration maps of chemical components in
cortical Aβ plaques
We compare the concentration maps of the four com-
ponents identified in Sec. III C over AD and control pop-
ulations in the cortex brain region. Rows 2-5 in Fig. 4
show the concentration maps, obtained from the analy-
sis on 31 unstained cortical Aβ plaques (6 AD patients)
together with 9 control Raman maps (2 age-matched hu-
mans without AD). Results are shown on examples of
Aβ plaques of three different morphologies: two neu-
ritic (40×40µm2 from Ac1 in column A, 64×64µm2 from
Ac2 in column B), core-only (55 × 55µm2 from Ac2 in
column C), cored neuritic (64×64µm2 from Ac3 in col-
umn D), and two control regions (64×64µm2 from Cc1 in
column E, and 32×32µm2 from Cc2 in column F). FM of
plaque and two control regions, stained with Thioflavin-
S, are shown in row 1, where white squares represent
the regions investigated with Raman micro-spectroscopy.
The corresponding DIC images of the same plaque and
control areas are shown in the Supporting Information
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FIG. 4: As Fig. 2, but for the cortex samples.
Fig. S44. White areas in panels B2-B5 represent pixels
which were excluded from the analysis due to too strong
fluorescence.
Compared to the hippocampal data, we find a similar
behaviour of C2 and C3. However, the collagen component
C1 is absent, and all plaques show large β-carotene (C4)
and iron oxide (C5) concentrations similar to the core-
only plaque in the hippocampal data. Also here, the
β-carotene tends to be in the periphery of the plaque.
We find that the concentration maps of the aggregated
Aβ peptides and saturated lipids with high cholesteryl
ester content (C2) in the plaque areas (Fig. 4(A2-D2))
correlate well with the corresponding fluorescent im-
ages of Thioflavin-S dye (Fig. 4(A1-D1)). The concentra-
tion maps of fibrin/arachidic acid (C3), β-carotene (C4)
and iron oxide (C5) across the different types of plaques
show their elevated micro-scale accumulations through-
out the entire plaque areas, highest at the fibrillar
core and lowest at the Aβ rim. In contrast to AD
plaque regions, the controls do not to contain sig-
nificant amounts of β-carotene (Fig. 4(E4,F4)) or iron
molecules (Fig. 4(E5,F5)). Notably, the fibrin/arachidic
acid component is found not only inside the plaque, but
also outside of it, whereas β-carotene and iron species are
exclusively observed inside the plaque.
The elevated deposits of β-carotene, iron oxide, Aβ fib-
rils, and saturated lipids, which are found to be co-
localised in Aβ plaques, can reflect the presence of neu-
roinflammation and a high level of neurotoxicity in the
AD brain. The oxidation status of lipids is supported
by the presence of trans double bonds in the Raman
spectrum of C2 (see Sec. III A), forming during lipid
peroxidation. Furthermore, the presence of arachidic
acid (eicosanoic acid) in C3 indicates the conversion of
arachidonic acids to eicosanoids occurring in the process
of oxidative damage. Notably, Raman bands which are
characteristic for secondary oxidation products, such as
short-chain hydrocarbons (produced from the reaction of
lipid hydroperoxide and redox metal), are obtained when
analyzing AD samples only in Aβ plaque regions (data
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FIG. 5: Colocalization histograms of concentration (%) for β-carotene (C4) and iron oxide (C5) components for each diseased
(4 AD patients) and control (2 subjects) cortex samples, which refer to AD and non-demented age-matched subjects, labelled
as Ac1 (A), Ac2 (B), Ac3 (C), Ac4 (D) and Cc1 (E), Cc2 (F), representing the statistics on 3, 13, 7, 2 plaques, and 4, 3 control
regions, respectively, each of about 50×50 µm2 in size.
not shown). Altogether, our data show that AD brains
contain huge amounts of oxidative stress markers, co-
localised with amyloid/lipids in Aβ plaques, and thereby
indicating the critical role of oxidative damage in AD
pathogenesis. In terms of Aβ plaque aggregation, it
is possible that the plaque environment, shown to con-
sist of abnormal micro-complexes of fibrin/arachidic acid,
saturated cholesteryl esters, β-carotene and iron oxide,
controls the degree of plaque aggregation/fragmentation
and, therefore, the neurotoxicity status of AD human
brains.
Colocalization histograms of concentration are shown
in Fig. 5, for the β-carotene (C4) and iron oxide (C5) com-
ponents of each diseased (4 AD patients) and control (2
age-matched subjects without AD) samples, using data
of 3, 13, 7, 2 plaques from Ac1, Ac2, Ac3, Ac4, and
4, 3 control regions from Cc1, Cc2 individuals, each of
about 50×50 µm2 in size. The corresponding concen-
tration histograms for Ac5 and Ac6 samples are shown
in the Supporting Information Fig. S45. The analysis of
the distribution histograms again reveals striking changes
in the concentrations of these components between AD
and control populations, indicating their potential capa-
bility to differentiate patients’ classes, similar to what
discussed for the hippocampus regions (see Sec. III B). In
particular, as can be seen from Fig. 5, taking the cut-off
value of the distributions histograms at concentrations of
5% and 3% for components 4 and 5, respectively, results
in only histograms for AD cohort having concentrations
higher than these values, therefore again indicating that
AD population of the cerebral cortex tissue can be sepa-
rated from non-demented age-matched group on the basis
of these concentration distributions.
IV. CONCLUSION
We have performed an extensive Raman micro-
spectroscopy study coupled with quantitative factoriza-
tion analysis in AD human brain tissues. We have found
micro-scale accumulations of chemical components at-
tributed to cholesteryl esters with saturated long-chain
FAs, Aβ fibrils, fibrin/arachidic acid, CLAC, β-carotene
and magnetite, co-localising in Aβ plaques of AD hu-
man brains. Notably, our study reveals that aggregated
Aβ peptide co-exists with saturated cholesteryl esters in
one complex, representing one chemical component. This
result suggests that cholesteryl esters might play an im-
portant role in Aβ metabolism. Our observations sup-
port previous in vitro studies, demonstrating that the
inhibition of ACAT function, which keeps the balance
between free cholesterol and cholesteryl ester levels in
the brain, down-regulates Aβ biosynthesis, therefore im-
plying the use of ACAT inhibitors as potential therapy in
the treatment of AD. Moreover, significant accumulation
and co-localisation of β-carotene and magnetite (Fe3O4)
with lipid aggregates and Aβ plaque cores suggests that a
high level of oxidative damage is implicated in AD human
brains. Importantly, we have shown, by the means of
colocalization histograms, that these chemical substances
can differentiate AD brains from non-demented ones, im-
plying their potential to be used in the diagnosis of AD.
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